市场调查报告书

脑膜炎疫苗的全球市场

Meningitis Vaccines Market

出版商 Research Nester 商品编码 830896
出版日期 内容资讯 英文 312 Pages
商品交期: 最快1-2个工作天内
价格
脑膜炎疫苗的全球市场 Meningitis Vaccines Market
出版日期: 2019年04月01日内容资讯: 英文 312 Pages
简介

本报告提供全球脑膜炎疫苗的市场相关分析,市场基本结构和最新形势,主要的推动及阻碍市场要素,整体市场趋势 (市场规模、成长率)的预测 (今后10年份),疫苗的各类型、各结构、各终端用户及地区别详细趋势,主要企业简介等调查。

第1章 简介

第2章 前提条件、简称一览

第3章 分析方法

第4章 摘要整理

第7章 市场动态

  • 推动市场要素
  • 阻碍市场要素
  • 市场趋势
  • 市场机会

第6章 风险分析

  • 需求风险
  • 供给风险

第7章 全球脑膜炎疫苗市场未来展望

  • 市场规模与其预测
    • 市场规模 (以金额为准,今后10年份)
      • 年度成长率 (以金额为准,今后10年份)
  • 市场占有率与其预测 (以金额为准,今后10年份)
    • 各疫苗
      • 脑膜炎疫苗 (MenB,MenC,MenACWY)
      • 肺炎球菌疫苗 (PCV,PPV)
      • Hib疫苗
      • 市场向心力分析:各疫苗
      • 市场占有率 (BPS) 分析:各疫苗
    • 各结构
      • 多糖体疫苗,结合型疫苗等
    • 各终端用户
      • 医院,诊所,当天返回手术中心 (ASC) 等
    • 各地区
      • 北美,欧洲,亚太地区,南美,中东、非洲

第8章 北美的脑膜炎疫苗市场未来展望

  • 宏觀经济指标
  • 市场规模与其预测 (以金额为准,总计9年份)
  • 市场占有率与其预测 (以金额为准,总计9年份)
    • 各疫苗
    • 各结构
    • 各终端用户
    • 各国 (美国,加拿大)

第9章 欧洲的脑膜炎疫苗市场未来展望

  • 宏觀经济指标
  • 市场规模与其预测 (以金额为准,总计9年份)
  • 市场占有率与其预测 (以金额为准,总计9年份)
    • 各国 (德国,英国,法国,义大利,西班牙,土耳其,俄罗斯等)

第10章 亚太地区的脑膜炎疫苗市场未来展望

  • 宏觀经济指标
  • 市场规模与其预测 (以金额为准,总计9年份)
  • 市场占有率与其预测 (以金额为准,总计9年份)
    • 各国 (印度,中国,日本,韩国,澳洲等)

第11章 南美的脑膜炎疫苗市场未来展望

  • 宏觀经济指标
  • 市场规模与其预测 (以金额为准,总计9年份)
  • 市场占有率与其预测 (以金额为准,总计9年份)
    • 各国 (北非各国,南非等)

第12章 中东、非洲的脑膜炎疫苗市场未来展望

  • 宏觀经济指标
  • 市场规模与其预测 (以金额为准,总计9年份)
  • 市场占有率与其预测 (以金额为准,总计9年份)
    • 各国 (美国,加拿大)

第13章 竞争环境

  • 主要企业的市场定位
  • 企业简介
    • GlaxoSmithKline plc
      • 企业概要
      • 事业策略 (成长、扩大策略,流通管道策略,产品策略)
      • 主要产品
      • 财务成果
      • KPI (重要业绩评估指标)
      • 风险分析
      • 近几年趋势
      • 各地区的存在感
      • SWOT分析
    • Pfizer Inc.
    • Sanofi Pasteur SA
    • Merck & Co., Inc.
    • Janssen
    • Panacea
    • Hualan Biological Engineering Inc.
    • Serum Institute of India Ltd.
目录

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

Global market of meningitis vaccine stood at USD 12,783.1 Million in 2018 and is expected to reach USD 27,522.5 Million by the end of 2027, expanding at a CAGR of 8.9% over the forecast period i.e. 2019-2027. The advancements in meningitis vaccine and growing healthcare sector globally is anticipated to further boost the demand for meningitis vaccine in future.

Geographically, North America accounted for the largest market share of 41.2% in 2018 in the revenue of meningitis vaccine market globally. The market of North America region is expected to continue its dominance over the forecast period on the back of rising demand for efficient disease preventive Vaccine across the region.

Robust research and development are going on in healthcare sector to manufacture advanced and cost-effective meningitis Vaccine. The advanced meningitis vaccine further provides precise and accurate dosing with minimalist side effects to the vaccinated population.

The adoption of advanced and high end Vaccine is rising in developing regions such as India, China, Japan and others. To gain a competitive edge, different manufacturers of medical equipment have come up with various new Vaccine to effectively aid in the prevention of meningitis.

With USD 5,999.9 Million revenue by the end of 2027 in global market, Asia-Pacific Meningitis Vaccine market is expected to showcase lucrative growth over the forecast period. This growth is primarily attributed on the back of increasing governing regulatory body initiatives in order to reduce the number of deaths caused to meningitis across the region.

With the increasing focus of people on healthcare, the Asia-Pacific meningitis vaccine market is expected to witness rapid growth throughout the forecast period. Asia-Pacific market is expected to expand at a CAGR of 9.4% over the forecast period and expected to contribute a market share of 21.8% in global meningitis vaccine market.

Additionally, favorable government initiatives to develop the healthcare infrastructure coupled with increasing healthcare expenditure across the globe is envisioned to bolster the growth of the meningitis Vaccine market robustly over the forecast period.

Moreover, Europe is estimated to grow at a CAGR of 8.7% over the forecast period contributing a market share of 25.6% in the year 2027 in the global meningitis market.

Some of the leading manufacturers in this market are Sanofi Pasteur, GSK, Pfizer, Merck and Essilor among others.

1. Introduction

  • 1.1. Market Definition
  • 1.2. Product Overview
  • 1.3. Market Segmentation
  • 1.4. Features by Popular Products Available

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Meningitis Vaccine Market

5. Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Trends
  • 5.4. Opportunities

6. Risk Analysis

  • 6.1. Demand Risk
  • 6.2. Supply Risk

7. Global Meningitis Vaccine Market Outlook

  • 7.1. Market Size and Forecast, 2018-2027
    • 7.1.1. By Value (USD Million)
      • 7.1.1.1. Y-o-Y Growth (%), 2019-2027
  • 7.2. Market Share and Forecast, 2018-2027
    • 7.2.1. By Vaccine
      • 7.2.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 7.2.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.1.2. Market Attractiveness Analysis, By Vaccine
      • 7.2.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 7.2.2. By Composition
      • 7.2.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 7.2.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.2.2. Market Attractiveness Analysis, By Composition
      • 7.2.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 7.2.3. By End User
      • 7.2.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 7.2.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.3.2. Market Attractiveness Analysis, By End User
      • 7.2.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 7.2.4. By Region
      • 7.2.4.1. Meningitis Vaccine Market Share (%), By Region (2018,2027F)
        • 7.2.4.1.1. North America
        • 7.2.4.1.2. Europe
        • 7.2.4.1.3. Asia Pacific
        • 7.2.4.1.4. Latin America
        • 7.2.4.1.5. Middle East and Africa

8. North America Meningitis Vaccine Market Outlook

8.1. Macro-Economic Indicators impacting the North America Meningitis Vaccine Market

  • 8.2. Market Size and Forecast, 2018-2027
    • 8.2.1. By Value (USD Million)
      • 8.2.1.1. Y-o-Y Growth (%), 2019-2027

8.3. Market Share and Forecast, 2018-2027

    • 8.3.1. By Vaccine
      • 8.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 8.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 8.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 8.3.2. By Composition
      • 8.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 8.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.2.2. Market Attractiveness Analysis, By Composition
      • 8.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 8.3.3. By End User
      • 8.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 8.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.3.2. Market Attractiveness Analysis, By End User
      • 8.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 8.3.4. By Country
      • 8.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 8.3.4.1.1. United States & Canada, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

9. Europe Meningitis Vaccine Market Outlook

  • 9.1. Macro-Economic Indicators impacting the Europe Meningitis Vaccine Market
  • 9.2. Market Size and Forecast, 2018-2027
    • 9.2.1. By Value (USD Million)
      • 9.2.1.1. Y-o-Y Growth (%), 2019-2027

9.3. Market Share and Forecast, 2018-2027

    • 9.3.1. By Vaccine
      • 9.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 9.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 9.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 9.3.2. By Composition
      • 9.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 9.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.2.2. Market Attractiveness Analysis, By Composition
      • 9.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 9.3.3. By End User
      • 9.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 9.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.3.2. Market Attractiveness Analysis, By End User
      • 9.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 9.3.4. By Country
      • 9.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 9.3.4.1.1. Germany, United Kingdom & France, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.4.1.2. Italy, Spain & Turkey, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.4.1.3. Russia & rest of Europe, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

10. Asia Pacific Meningitis Vaccine Market Outlook

  • 10.1. Macro-Economic Indicators impacting the Asia Pacific Meningitis Vaccine Market
  • 10.2. Market Size and Forecast, 2018-2027
    • 10.2.1. By Value (USD Million)
      • 10.2.1.1. Y-o-Y Growth (%), 2019-2027

10.3. Market Share and Forecast, 2018-2027

    • 10.3.1. By Vaccine
      • 10.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 10.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 10.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 10.3.2. By Composition
      • 10.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 10.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.2.2. Market Attractiveness Analysis, By Composition
      • 10.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 10.3.3. By End User
      • 10.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 10.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.3.2. Market Attractiveness Analysis, By End User
      • 10.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 10.3.4. By Country
      • 10.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 10.3.4.1.1. India, China and Japan, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.4.1.2. South Korea, Australia & Rest of Asia Pacific 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

11. Latin America Meningitis Vaccine Market Outlook

  • 11.1. Macro-Economic Indicators impacting the Latin America Meningitis Vaccine Market
  • 11.2. Market Size and Forecast, 2018-2027
    • 11.2.1. By Value (USD Million)
      • 11.2.1.1. Y-o-Y Growth (%), 2019-2027

11.3. Market Share and Forecast, 2018-2027

    • 11.3.1. By Vaccine
      • 11.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 11.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 11.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 11.3.2. By Composition
      • 11.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 11.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.2.2. Market Attractiveness Analysis, By Composition
      • 11.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 11.3.3. By End User
      • 11.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 11.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.3.2. Market Attractiveness Analysis, By End User
      • 11.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 11.3.4. By Country
      • 11.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 11.3.4.1.1. Brazil, Mexico & Rest of Latin America, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

12. Middle East and Africa Meningitis Vaccine Market Outlook

  • 12.1. Macro-Economic Indicators impacting the Middle East and Africa Meningitis Vaccine Market
  • 12.2. Market Size and Forecast, 2018-2027
    • 12.2.1. By Value (USD Million)
      • 12.2.1.1. Y-o-Y Growth (%), 2019-2027

12.3. Market Share and Forecast, 2018-2027

    • 12.3.1. By Vaccine
      • 12.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 12.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 12.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 12.3.2. By Composition
      • 12.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 12.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.2.2. Market Attractiveness Analysis, By Composition
      • 12.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 12.3.3. By End User
      • 12.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 12.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.3.2. Market Attractiveness Analysis, By End User
      • 12.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 12.3.4. By Country
      • 12.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 12.3.4.1.1. Middle East & Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.4.1.1.1. North Africa, South Africa & Rest of Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

13. Competitive Landscape

  • 13.1. Competitive Positioning of Major Players in Global Meningitis Vaccine Market
  • 13.2. Company Profiles
    • 13.2.1. GlaxoSmithKline plc
      • 13.2.1.1. Company Overview
      • 13.2.1.2. Business Strategy
        • 13.2.1.2.1. Growth Expansion Strategy
        • 13.2.1.2.2. Distribution Channel Strategy
        • 13.2.1.2.3. Product Strategy
      • 13.2.1.3. Key Product Offerings
      • 13.2.1.4. Financial Performance
      • 13.2.1.5. Key Performance Indicators
      • 13.2.1.6. Risk Analysis
      • 13.2.1.7. Recent Development
      • 13.2.1.8. Regional Presence
      • 13.2.1.9. SWOT Analysis
    • 13.2.2. Pfizer Inc.
    • 13.2.3. Sanofi Pasteur SA
    • 13.2.4. Merck & Co., Inc.
    • 13.2.5. Janssen
    • 13.2.6. Panacea
    • 13.2.7. Hualan Biological Engineering Inc.
    • 13.2.8. Serum Institute of India Ltd.